These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6626116)

  • 1. The effects of intracoronary Renografin injection on coronary flow and distribution in dogs following coronary occlusion.
    Cohen MV
    Basic Res Cardiol; 1983; 78(4):364-72. PubMed ID: 6626116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary angiography with iopamidol and Renografin 76 in normal and pulmonary hypertensive dogs.
    Thompson WM; Mills SR; Bates M; Hedlund L; Rommel J
    Acta Radiol Diagn (Stockh); 1983; 24(5):425-31. PubMed ID: 6666667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the hemodynamic effects of Hexabrix and Renografin-76 following left ventriculography and coronary arteriography.
    Svenson RH
    Invest Radiol; 1984; 19(6 Suppl):S333-4. PubMed ID: 6392162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of myocardial biochemical toxicity with a nonionic contrast agent (iopamidol).
    Wisneski JA; Gertz EW; Neese RA; Morris DL
    Am Heart J; 1985 Sep; 110(3):609-17. PubMed ID: 4036786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind clinical comparison of the electrophysiologic adverse effects of Hexabrix and Renografin-76.
    Wolf GL
    Invest Radiol; 1984; 19(6 Suppl):S328-32. PubMed ID: 6392161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of Renografin-76 on the ischemic and nonischemic myocardium.
    Yamazaki H; Banka VS; Bodenheimer MM; Hattori S; Agarwal JB; Helfant RH
    Am J Cardiol; 1981 Mar; 47(3):597-602. PubMed ID: 6781323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
    Gertz EW; Wisneski JA; Chiu D; Akin JR; Hu C
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):250-8. PubMed ID: 3881496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography.
    Moore CA; Smucker ML; Kaul S
    J Am Coll Cardiol; 1986 Nov; 8(5):1066-72. PubMed ID: 3760381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the hemodynamic effects of intravenous administration of ionic and nonionic contrast materials. Implications for deriving physiologic measurements from computed tomography and digital cardiovascular imaging.
    Higgins CB; Gerber KH; Mattrey RF; Slutsky RA
    Radiology; 1982 Mar; 142(3):681-6. PubMed ID: 7063684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low osmolality contrast materials on coronary hemodynamics, myocardial function, and coronary sinus osmolality in normal and ischemic states.
    Deutsch AL; Gerber KH; Haigler FH; Higgins CB
    Invest Radiol; 1982; 17(3):284-91. PubMed ID: 7118517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial contrast two-dimensional echocardiography: comparison of contrast disappearance rates in normal and underperfused myocardium.
    Maurer G; Ong K; Haendchen R; Torres M; Tei C; Wood F; Meerbaum S; Shah P; Corday E
    Circulation; 1984 Feb; 69(2):418-29. PubMed ID: 6690107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective coronary arteriography: a clinical comparison of two contrast agents.
    Shirey EK; Sones FM; Greenstreet RL
    Cathet Cardiovasc Diagn; 1983; 9(4):345-52. PubMed ID: 6627384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hemodynamic effects of Hypaque-76 and Renografin-76 during coronary angiography: the role of calcium-binding additives.
    Hwang MH; Murdock DK; Piao ZE; Gries WJ; Scanlon PJ
    Cathet Cardiovasc Diagn; 1988; 15(1):5-10. PubMed ID: 3136927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracoronary administration of contrast media on coronary hemodynamics in a canine post ischemic reperfusion model.
    Sheu SH; Hwang MH; Piao ZE; Hariman RJ; Loeb HS; Scanlon PJ
    Cathet Cardiovasc Diagn; 1991 Jun; 23(2):144-49. PubMed ID: 2070405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable effect of nifedipine on myocardial blood flow at three grades of coronary occlusion in the dog.
    Weintraub WS; Hattori S; Agarwal J; Bodenheimer MM; Banka VS; Helfant RH
    Circ Res; 1981 Jun; 48(6 Pt 1):937-42. PubMed ID: 7226452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intracoronary meglumine diatrizoate on regional myocardial contractility and the protective effect of hydrocortisone.
    Pasternak RC; Lewis BS; Gotsman MS; Merin G
    Isr J Med Sci; 1980 Mar; 16(3):185-90. PubMed ID: 7390758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fibrillation during coronary angiography: reduced incidence in man with contrast media lacking calcium binding additives.
    Murdock DK; Johnson SA; Loeb HS; Scanlon PJ
    Cathet Cardiovasc Diagn; 1985; 11(2):153-9. PubMed ID: 3921258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion of ischemic myocardium during anesthesia with sevoflurane.
    Kersten JR; Brayer AP; Pagel PS; Tessmer JP; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):995-1004. PubMed ID: 7943851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ventricular fibrillation threshold induced by contrast agents during acute coronary artery occlusion.
    Wolf GL; Mulry CS; Laski PA; Kilzer K
    Invest Radiol; 1983; 18(2):145-8. PubMed ID: 6862805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative hemodynamic effects of coronary vasodilators and contrast material on the normal and ischemic canine myocardium: determination of the optimal agent for clinical augmentation of coronary blood flow.
    Higgins CB; Bookstein JJ
    Invest Radiol; 1977; 12(4):299-306. PubMed ID: 407173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.